Trial Profile
Open label clinical trial with rituximab (MabThera) in ankylosing spondylitis
Status:
Not yet recruiting
Phase of Trial:
Phase II/III
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Rituximab (Primary)
- Indications Ankylosing spondylitis
- Focus Therapeutic Use
- 16 Mar 2007 New trial record.